RecruitingNCT04423484

Therapeutic Recommendations for Nephroblastoma

Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.


Sponsor

French Africa Pediatric Oncology Group

Enrollment

1,000 participants

Start Date

Jul 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.


Eligibility

Min Age: 6 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects clinical data and follows the treatment outcomes of children diagnosed with Wilms tumor (also called nephroblastoma) — one of the most common kidney cancers in children. By gathering information from multiple centers, researchers aim to refine treatment guidelines and improve survival rates and quality of life for affected children. **You may be eligible if...** - Your child has been newly diagnosed with Wilms tumor affecting one kidney (unilateral) - Your child has not yet received any treatment for the tumor - Your child's overall health permits treatment to proceed - Your family consents to participate **You may NOT be eligible if...** - Your child has Wilms tumor affecting both kidneys (bilateral) - Your child has already received prior treatment for the tumor - The disease is too advanced or the diagnosis is uncertain - Parents or guardians refuse participation in the treatment protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection

Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.


Locations(7)

Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle

Ouagadougou, Burkina Faso

CHU de Treichville à ABIDJAN

Abidjan, Abidjan Autonomous District, Côte d’Ivoire

CUK (Cliniques Universitaires de Kinshasa)

Kinshasa, Democratic Republic of the Congo

Cliniques Universitaires de Lubumbashi (CUL)

Lubumbashi, Democratic Republic of the Congo

HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona

Antananarivo, Madagascar

CHU Gabriel Touré (HGT)

Bamako, Mali

Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001

Dakar, Dakar, Senegal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04423484


Related Trials